Oconnell Daniel Joseph
CIK 0001865136
President and CEODirector
Filings
10
Latest Jan 23, 2026
Issuers covered
1
Showing
10 of 10
Page 1
Track record
11 of 11 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 11 | 27% | -18.7% | -23.7% | +21.1% | -48.8% |
| 90 days | 11 | 27% | -21.1% | -38.7% | +48.0% | -50.8% |
| 180 days | 3 | 100% | +20.2% | +15.2% | +40.5% | +4.9% |
| 365 days | 3 | 33% | +13.2% | -4.2% | +55.0% | -11.0% |
Issuers
Companies where Oconnell Daniel Joseph has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ABOS | Acumen Pharmaceuticals, Inc. | 10 | Jan 23, 2026 |
All filings
10 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|